CPHI Exhibition
October 2025 – Frankfurt — Quinovare is pleased to announce that its leadership team will be attending the upcoming CPHI Exhibition, taking place from October 28–30, 2025. The event gathers global leaders in the pharmaceutical industry to explore the latest innovations and partnerships shaping the future of healthcare.
Advancing Needle-Free Injection Technology
At Quinovare, we are committed to advancing needle-free injection technologies that deliver medicines with precision, safety, and comfort. Our innovative solutions support a wide range of applications, including vaccines, biologics, insulin, and chronic disease treatments, helping to improve patient experience and compliance while reducing risks associated with traditional needles.
During the exhibition, Quinovare representatives will be available for meetings with industry partners and collaborators to explore potential opportunities for integrating our technology into next-generation drug delivery systems. Additionally, our needle-free injector will be available for viewing at Hall 11 Booth 1B39, offering visitors a closer look at the design, functionality, and advantages of our latest innovation.
We believe needle-free technology will play a vital role in transforming modern drug delivery and enhancing global access to safer, more effective treatments.
About Quinovare
Quinovare focuses on the innovation and application of needle-free injection technology, delivering efficient, safe, and user-friendly drug delivery solutions for the global pharmaceutical industry. With a strong foundation in research and a growing international presence, Quinovare’s technologies are trusted across multiple therapeutic areas for their precision and reliability.
Contact Information
For more information or to schedule a meeting during CPHI, please contact: